Testosterone Therapy in Heart Failure

• Status: Withdrawn
• Trial end date: 2012-12-01

Summary

The purpose of this study is to evaluate whether benefits of topical testosterone on symptoms and function of male HF patients, and its effects on rehospitalization rates and quality of life.

• Phase: N/A

Details

• Lead Sponsor: Cedars-Sinai Medical Center
• Collaborator: Abbott
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate